
Please try another search
Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets. The company also provides nervous system products, such as piracetam series, levetiracetam series, vinpocetine, and other products; narcotics and narcotic-containing products, including morphine hydrochloride injection, pethidine hydrochloride injection, morphine hydrochloride tablets, oxycodone hydrochloride injection, and other products; anti-AIDS products comprising kedu/zidovudine tablets, kedu/zidovudine capsules, efavirenz tablets, zidolamid bivudine tablets, and other products; and in vitro biological diagnostic reagent products, such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. In addition, it offers general health products, including vitamin C powder, effervescent tablets, chewable tablets, solid drinks, glycosaminoglycan chondroitin sulfate collagen D3 calcium capsules, protein powder, probiotic powder, and other products. Further, the company provides Zhengchangsheng aluminum carbonate magnesium chewable tablets; Zhenxiwei compound proglumide and cimetidine tablets; amlodipine maleate; compound licorice series; narcotine syrup; Kefei, a compound codeine phosphate syrup; Xiaoke, a citronix tablets; acetaminophen tablets, pain-relieving tablets; metronidazole tablets; tinidazole tablets; paracetamol tablets; and other products. Additionally, it engages in medical distribution business. The company was founded in 1946 and is based in Shenyang, China.
Name | Age | Since | Title |
---|---|---|---|
Hai Tian | - | - | Supervisor |
Zhou Kai | 61 | 2019 | Chairman of the Board |
Chengren Huang | 61 | 2018 | Non-Independent Director |
Xinhua Ao | 61 | 2018 | Non-Independent Director |
Liqin Chen | 60 | 2021 | Non-Employee Supervisor |
Jianmin Guo | 54 | 2021 | Director |
Zhihua Huang | 57 | 2021 | Non-Independent Director |
Baidan Zhan | 51 | 2018 | Chairman of the Supervisory Board |
Lin Yang | 41 | 2023 | Supervisor |
Yongwei Huang | - | 2025 | Independent Director |
Yonggang Cai | 45 | 2024 | General Manager & Director |
Wang Xinpeng | - | 2025 | Director |
Cao Yue | - | 2025 | Independent Director |
Xingming Liu | - | 2025 | Independent Director |
Haitian Ma | - | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review